Treatment of urethral sphincter mechanism incompetence in 11 bitches with a sustained-release formulation of phenylpropanolamine hydrochloride

Veterinary Record

Volumn 151, Issue 13, 2002, Pages 373-376

  Bacon, N J ^a   Oni, O ^a   White, R A S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; CEFALEXIN; DIETHYLSTILBESTROL; DIPHENYLPYRALINE; DIPHENYLPYRALINE PLUS PHENYLPROPANOLAMINE; ESTROGEN; PHENOBARBITAL; PHENYLPROPANOLAMINE; SULFONAMIDE;

ARTICLE; BLADDER SPHINCTER; COLPOSUSPENSION; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MECHANISM; FEMALE; NONHUMAN; SUSTAINED RELEASE FORMULATION; TREATMENT FAILURE; TREATMENT OUTCOME; URINE INCONTINENCE;

CANIDAE; CANIS FAMILIARIS;

EID: 0037190460     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.151.13.373     Document Type: Article

References (33)

1. ADAMS, W. M. & DIBARTOLA, S. P. (1983) Radiographic and clinical features of pelvic bladder in the dog. Journal of the American Veterinary Medical Association 182, 1212-1217
2. ASCHAN, G. (1974) Decongestion of nasal mucous membranes by oral medication in acute rhinitis. Acta Oto-laryngologica 77, 433-438
3. BARRY, R. H., WEISS, M., JOHNSON, J. B. & DERITTER, E. (1982) Stability of phenylpropanolamine hydrochloride in liquid formulations containing sugars. Journal of Pharmaceutical Sciences 71, 116-118
4. CAMMU, H. & VAN NYLEN, M. (1995) Pelvic floor muscle exercise: 5 years later. Urology 38, 332-337
5. DOWSE, R., HAIGH, J. M. & KANFER, I. (1987) Pharmacokinetics of phenylpropanolamine in humans after a single-dose study. International Journal of Pharmaceutics 39, 141-148
6. EK, A., ALM, P., ANDERSSON, K. E. & PERSSON, C. G. A. (1977) Adrenoreceptor and cholinoceptor mediated responses of the isolated human urethra. Scandinavian Journal of Urology and Nephrology 11, 97-107
7. FENNER, W. R. (1993) Neuroloical disorders of micturition. In Disease Mechanisms in Small Animal Surgery. 2nd edn. Ed M. J. Bojrab. Malvern, Lea & Febiger. pp 520-527
8. GREGORY, S. P. (1994) Developments in the understanding of the pathophysiology of urethral sphincter mechanism incompetence in the bitch. British Veterinary Journal 150, 135-150
9. GREGORY, S. P. & HOLT, P. E. (1992) Effect of body position on intravesicular pressure in the anaesthetised bitch. Veterinary Record 130, 288-290
10. HOLT, P. E. (1985) Urinary incontinence in the bitch due to sphincter mechanism incompetence: prevalence in referred dogs and retrospective analysis of sixty cases. Journal of Small Animal Practice 26, 181-190
11. HOLT, P. E. (1990) Longterm evaluation of colposuspension in the treatment of urinary incontinence due to incompetence of the urethral sphincter mechanism in the bitch. Veterinary Record 127, 537-542
12. HOLT, P. E. (1993) Association in bitches between breed, size, neutering and docking, and acquired urinary incontinence due to incompetence of the urethral sphincter mechanism. Veterinary Record 133, 177-180
13. HOLT, P. E. (1999) Diagnosis and management of canine urethral sphincter mechanism incompetence. Waltham Focus 9, 19-23
14. HOLT, P. E. & JONES, A. (2000) In vitro study of the significance of bladder neck position in incontinent bitches. Veterinary Record 146, 437-439
15. HUSSAIN, M. A., AUNGST, B. J., LAM, G. & SHEFTER, E. (1987) Phenylpropanolamine pharmacokinetics in dogs after IV, oral and oral controlled-release doses. Biopharmaceutics and Drug Disposition 8, 497-505
16. KHANNA, O. P., BARBIERIR, E. J., ALTAMURA, M. & MCMICHAEL, R. (1981) Vesicourethral smooth muscle: function and relation to structure. Urology 18, 211-218
17. KUBO, N., SHIRAKAWA, O., KUNO, T. & TANAKA, C. (1987) Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay. Japanese Journal of Pharmacology 42, 277-282
18. LASAGNA, L. (1988) Phenylpropanolamine: a review. In Basic Pharmacology. New York, John Wiley & Sons. pp 84-190
19. LÖNNERHOLM, G., GRAHNÉN, A. & LINDSTRÖM, B. (1984) Steady-state kinetics of sustained-release phenylpropanolamine. Internal Journal of Clinical Pharmacology, Therapy and Toxicology 22, 39-41
20. MCGUIRE, E. J. (1978) Experimental observations on the integration of bladder and urethral function. Investigative Urology 15, 303-307
21. NERGÅRDH, A., & BORÉUS, L. O. (1973) The functional role of cholinergic receptors in the outlet region of the urinary bladder: an in vitro study in the cat. Acta Pharmacologica et Toxicologica 32, 467-480
22. NICKEL, R. F. & VAN DEN BROM, W. E. (1997) Simultaneous diuresis cystourethrometry and multi-channel urethal pressure profilometry in female dogs with refractory urinary incontinence. American Journal of Veterinary Research 58, 691-696
23. NICKEL, R. F., VINK-NOTEBOOM, M. & VAN DEN BROM, W. E. (1999) Clinical and radiographic findings compared with urodynamic findings in neutered female dogs with refractory urinary incontinence. Veterinary Record 145, 11-15
24. O'BRIEN, D. (1988) Neurogenic disorders of micturition. Veterinary Clinics of North America: Small Animal Practice 18, 529-544
25. PRAPAITRAKUL, W. & WHITWORTH, C. W. (1989) Microencapsulation of phenylpropanolamine to achieve sustained release. Journal of Microencapsulation 6, 213-218
26. REES, D. L. P. & RANSLEY, P. G. (1980) Eskornade in the treatment of diurnal incontinence in children. British Journal of Urology 52, 476-479
27. RICHTER, K. P. & LING, G. V. (1985) Clinical response to urethral pressure profile changes after phenylpropanolamine in dogs with primary sphincter incompetence. Journal of the American Veterinary Medical Association 187, 605-611
28. ROSIN, A. H. & ROSS, L. (1981) Diagnosis and pharmacological management of disorders or urinary continence in the dog. Compendium on Continuing Education for the Practicing Veterinarian 3, 601-610
29. SEVGI, F., ÖZYAZICI, M. & GÜNERI, T. (1994) Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: formulation and in vitro release kinetics from tableted microcapsules. Journal of Microencapsulation 11, 335-344
30. SHARGEL, L., SILVERMAN, H. I., COHEN, P., BRISSON, J. & DENNIS, S. (1990) Bioavailability and cardiovascular safety of Dexatrim (phenylpropanolamine hydrochloride) from a controlled-release caplet. Biopharmaceutics and Drug Disposition 11, 569-583
31. THAKAR, R. & STANTON, S. (2000) Management of urinary incontinence in women. British Medical Journal 321, 1326-1331
32. TODD, J. K. & MACK, A. J. (1969) A study of human destrusor muscle. British Journal of Urology 41, 448-454
33. WHITE, R. A. S. & POMEROY, C. J. (1989) Phenylpropanolamine: an alpha-adrenergic agent for the management of urinary incontinence in bitches associated with urethral sphincter mechanism incompetence. Veterinary Record 125, 478-480